Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04576156 |
|---|---|
| Brief Title: | A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment |
| First Submitted : | September 18, 2020 |
| First Submitted that Met QC Criteria : | October 2, 2020 |
| First Posted : | October 6, 2020 |
| Last Update Submitted that Met QC Criteria : | March 14, 2023 |
| Last Update Posted : | March 15, 2023 |